nobody
nothing

2019-08-30 11:29
(2140 d 21:36 ago)

Posting: # 20530
Views: 2,813
 

 BE in hepatic impairment? [BE/BA News]

Post reply
Hello again!

Today I have to read this here:

https://www.fdanews.com/articles/192544-persion-petitions-fda-to-raise-the-safety-bar-for-extended-release-opioid

But the originator found differences in PK in mild/moderate hepatic impairment not worth any dose adjustment according to the current label and the differences as outlined in the FDA AssRep are unimpressive. I'm trying to figure out a formulation-related influence of hepatic function on BA/BE...

Lawyers looking for some work? How low can you go? Is that state-of-the-art in 2019?
—
Kindest regards, nobody
 
UA Flag
Activity
 Admin contact
23,428 posts in 4,929 threads, 1,684 registered users;
56 visitors (0 registered, 56 guests [including 26 identified bots]).
Forum time: 09:05 CEST (Europe/Vienna)

To know that we know what we know,
and to know that we do not know what we do not know,
that is true knowledge.    Nicolaus Copernicus

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5